Middle East and Africa PCR Multiplex Assays Market, By Products & Services (Reagents & Consumables, Instruments & Accessories, and Software and Services), Applications (Clinical Diagnostics and Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others) -Industry Trends and Forecast to 2030.
Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Analysis and Size
Multiplex assays are a new technology that is incorporated with the capability to run more than one target sequence in a single step, the evolution of the polymerase chain reaction (PCR) multiplex assays in terms of smart features with voice command, facial authentication, and radio-frequency identification (RFID) features changes from a manual instrument to an automated PCR multiplexes systems. Major factors that are expected to boost the growth of the polymerase chain reaction (PCR) multiplex assays market in the forecast period are the range advantages offered by polymerase chain reaction (PCR) multiplex assays, such as multiple sequences in a single reaction are cost-effective, accurate, reliable, and rapid. Furthermore, growing expenditure to enhance the healthcare infrastructure is further anticipated to propel the growth of the polymerase chain reaction (PCR) multiplex assays market. On the other hand, the lack of skilled professionals or trained expertise is further projected to impede the growth of the polymerase chain reaction (PCR) multiplex assays market in the timeline period. However, the complicated nature of polymerase chain reaction (PCR) multiplex assays instruments might further challenge the growth of the polymerase chain reaction (PCR) multiplex assays market shortly.
The product & services segment is dominating the Polymerase Chain Reaction (PCR) Multiplex Assays Market due to the rising incidence of chronic diseases and the growing population.
Data Bridge Market Research analyses that the Polymerase Chain Reaction (PCR) Multiplex Assays Market was valued at USD 773.55 million in 2022 and is further estimated to reach USD 1,042.47 million by 2030, and is expected to grow at a CAGR of 3.80% during the forecast period of 2023 to 2030. The Data Bridge Market Research team curated market report includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Products & Services (Reagents & Consumables, Instruments & Accessories, and Software and Services), Applications (Clinical Diagnostics and Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA)
|
|
Market Players Covered
|
Hologic Inc. (U.S.), Luminex Corporation. A DiaSorin Company (U.S.), BD. (U.S.), Abbott. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Agilent Technologies Inc. (U.S.), MESO SCALE DIAGNOSTICS, LLC (U.S.), Randox Laboratories Ltd. (UK), Bio-Techne (U.S.), Seegene Inc. (South Korea), Olink (Sweden), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Abcam plc (UK), Quanterix (U.S.), Sysmex Corporation (Japan), Siemens (Germany), DiaSorin S.p.A. (Italy) , Quest Diagnostics Incorporated (U.S.), PerkinElmer Inc. (U.S.), Eurofins Scientific (Luxembourg), Agena Bioscience, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), among other
|
|
Market Opportunities
|
|
Market Definition
Polymerase chain reaction (PCR) multiplex assays are advanced molecular diagnostic tools that enable the simultaneous amplification and detection of multiple DNA or RNA targets in a single reaction. These assays are extensively employed in various applications, such as infectious disease diagnostics, genetic testing, forensics, and research. Additionally, PCR multiplex assays are invaluable tools for research purposes. They enable scientists to study the expression of multiple genes or detect the presence of specific genetic sequences simultaneously. This is particularly useful in fields such as cancer research, where the analysis of multiple genetic markers can provide insights into disease progression, prognosis, and therapeutic response.
Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Dynamics
Drivers
- Increasing Prevalence of Infectious Diseases
The Middle East and Africa region witness a significant burden of infectious disease, including respiratory infections, gastrointestinal infections, sexually transmitted diseases, and vector-borne diseases. The growing prevalence of these diseases drives the demand for PCR multiplex assays, as they offer rapid and accurate detection of multiple pathogens, aiding in effective disease management and control.
- Rising Adoption of Personalized Medicine
Increasing trend toward personalized medicine in the Middle East and Africa region. PCR multiplex assays play a crucial role in personalized medicine by enabling the detection of genetic variations associated with drug response, disease susceptibility, and treatment efficacy. The growing demand for customized medicine drives the adoption of PCR multiplex assays in the region.
- Advancements in Molecular Diagnostics
Technological advancements in PCR techniques and molecular diagnostics have enhanced the performance and efficiency of PCR multiplex assays. The development of advanced PCR platforms, novel reagents, and improved assay design has facilitated the simultaneous detection of multiple targets with higher sensitivity and specificity. These advancements drive the adoption of PCR multiplex assays in the Middle East and Africa.
Opportunity
- Increasing Focus on Precision Medicine
Precision medicine, which aims to tailor medical treatments to individual patients based on their genetic characteristics, is gaining traction in the Middle East and Africa region. PCR multiplex assays offer a powerful tool for genetic profiling and identification of genetic markers associated with specific diseases. The growing focus on precision medicine presents a significant opportunity for the expansion of the PCR multiplex assays market.
- Growing Demand for Point-of-Care Testing
There is an increasing demand for rapid and accurate diagnostic tests at the point of care in the Middle East and Africa region. PCR multiplex assays, with their ability to detect multiple targets in a single reaction, can be utilized as point-of-care tests for infectious diseases, genetic testing, and other applications. The rising demand for point-of-care testing creates opportunities for the PCR multiplex assays market.
Restraint
- High Cost of PCR Multiplex Assays
The cost associated with PCR multiplex assays, including equipment, reagents, and maintenance, can significantly restrain market growth in the Middle East and Africa region. Limited healthcare budgets and affordability may hinder the widespread adoption of PCR multiplex assays, particularly in resource-constrained settings, leading to slower market growth.
Challenge
- Limited Infrastructure and Skilled Workforce
The Middle East and Africa region faces challenges in terms of limited infrastructure and a shortage of skilled professionals in the field of molecular diagnostics. They are establishing and maintaining the necessary laboratory infrastructure. Establishing and maintaining the required laboratory infrastructure can be a time-consuming and costly. It involves acquiring PCR instruments, thermocyclers, centrifuges, and other essential laboratory equipment. Additionally, a reliable power supply and access to quality reagents and consumables are crucial for conducting PCR multiplex assays. Inadequate infrastructure can limit the capacity to perform these assays efficiently and may lead to delays in diagnosis or unreliable test results.
This Middle East and Africa polymerase chain reaction (PCR) multiplex assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa polymerase chain reaction (PCR) multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In October 2021, Bio-Rad Laboratories launched the Reliance One-Step Multiplex Supermix, a PCR multiplex assay designed to rapidly and accurately detect respiratory pathogens. This product launch by Bio-Rad Laboratories in 2021 is a significant development in the PCR multiplex assays market
- In July 2021, Bioneer Corporation partnered with Seegene Inc. to develop a multiplex PCR assay to detect COVID-19 variants and other respiratory pathogens. The partnership between Bioneer Corporation and Seegene Inc. aims to develop a multiplex PCR assay for detecting COVID-19 variants and other respiratory pathogens.
- In August 2020, Luminex Corporation acquired MilliporeSigma's flow cytometry and multiplex assay product portfolio, expanding its offerings in multiplex PCR assays and other molecular diagnostic technologies. This strategic move allowed Luminex to expand its offerings in multiplex assays and strengthen its position in the molecular diagnostics market
Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Scope
The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market is segmented based on products & services, applications, and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Product & Services
- Reagents and consumables
- Instruments and accessories
- Software and services
Application
- Research and development
- Clinical diagnostics
End User
- Pharmaceutical and biotechnology companies
- Research institutes
- Hospitals
- Clinical laboratories others
Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Regional Analysis/Insights
The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market is analyzed, and market size insights and trends are provided by country, type, and end-user, as referenced above.
The countries covered in the Middle East and Africa polymerase chain reaction (PCR) multiplex assays market report are the Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).
Saudi Arabia is expected to dominate and witness significant growth in the market due to growing applications of polymerase chain reaction (PCR) multiplex assays in research and development.
The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future market trends. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Polymerase Chain Reaction (PCR) Multiplex Assays Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Market. The data is available for historic period 2015-2020.
Competitive Landscape and Middle East and Africa Polymerase Chain Reaction (PCR) Multiplex Assays Market Share Analysis
The Middle East and Africa polymerase chain reaction (PCR) multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Middle East and Africa polymerase chain reaction (PCR) multiplex assays market.
Some of the major players operating in the Middle East and Africa polymerase chain reaction (PCR) multiplex assays market are:
- Hologic Inc. (U.S.)
- Luminex Corporation. A DiaSorin Company (U.S.)
- BD. (U.S.)
- Abbott. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- Agilent Technologies Inc. (U.S.)
- MESO SCALE DIAGNOSTICS, LLC (U.S.)
- Randox Laboratories Ltd. (UK)
- Bio-Techne (U.S.)
- Seegene Inc. (South Korea)
- Olink (Sweden)
- Illumina, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Abcam plc (UK)
- Quanterix (U.S.)
- Sysmex Corporation (Japan)
- Siemens (Germany)
- DiaSorin S.p.A. (Italy)
- Quest Diagnostics Incorporated (U.S.)
- PerkinElmer Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Agena Bioscience, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
SKU-